Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
N-Butanol comes with an interesting backstory, dating back to early discoveries in the 19th century. The initial synthesis tied directly to fermentation processes, which sparked curiosity in European chemical circles. Over decades, improved distillation methods allowed scientists to craft purer samples, which led to wide adoption. Before petrochemical routes dominated, n-Butanol was almost exclusively made by fermenting sugars and starch, much like ethanol manufacture. Post-World War II, large-scale industries switched to chemical synthesis via the oxo process—reacting propylene with carbon monoxide and hydrogen—which remains the preferred route for modern production. Pharmaceutical standards like BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) developed to ensure the compound meets the tightening demands of medicine and laboratory work. Stringent guidelines arose from hard-learned lessons, as contamination and inconsistencies posed real dangers in clinical applications.
N-Butanol appears as a clear colorless liquid, easily identified by its strong, recognizably alcoholic odor. It plays a supporting role in many areas—solvent, intermediate, and extraction agent—thanks to its balance between water and lipid solubility. Within pharmaceutical settings, the BP, EP, and USP grades mark n-Butanol produced under rigorous, globally accepted standards, demanding high purity and low levels of trace contaminants. These specifications cement their use in sensitive applications, including drug formulation and laboratory analysis. Engineers and pharmacists alike value n-Butanol for its predictable performance, but also for its reliability in controlled environments.
N-Butanol's molecular formula, C4H10O, gives it four carbon atoms and a single hydroxyl group. It presents a boiling point near 117 °C, and a melting point close to -89 °C, which lets it behave as a liquid at room temperature across most settings. Its density stays lower than water, floating atop if the two ever intermingle. As a moderately polar substance, n-Butanol mixes with most organic solvents. Even so, it only dissolves modestly in water, striking a convenient middle ground: not as volatile as methanol or ethanol, and not as greasy as longer alcohols. This molecular character lets it act as both a solvent and a building block for further synthesis.
Pharma grade n-Butanol must clear a high bar to earn BP, EP, or USP status. Impurities such as aldehydes, ketones, peroxides, and heavy metals must test far below strict thresholds. Residual solvents, water content, and any byproducts need tracking down to parts per million. Labels clearly highlight batch numbers, expiry dates, manufacturer details, and storage advice—at most two years, below 25 °C, in tightly sealed glass or HDPE containers. For anyone responsible for compliance, those labels offer peace of mind and, more importantly, regulatory protection if questions arise down the road.
Industrial preparation now relies mostly on the hydroformylation (oxo) process, sparing the unpredictability seen with fermentation. Refineries start by extracting propylene from petroleum streams, then subject it to high-pressure reactions with carbon monoxide and hydrogen. That creates butyraldehyde, which receives hydrogenation to convert into n-Butanol. The method generates a steady, scalable yield. Anyone who works in production or chemical engineering knows the headaches that arise from variable fermentation yields or contamination, so this process has become a mainstay in the industry. Small tweaks to catalysts and reaction conditions control final output and purity.
N-Butanol willingly participates in a catalog of organic reactions. It forms esters, ethers, and halides with ease. React it with acids and you get butyl esters, common in flavors and fragrances. Oxidizing agents transform it into butanal, then butyric acid. Dehydration produces butenes—useful intermediates in polymer chemistry. In pharmaceutical synthesis, many see n-Butanol as a blocking group or leaving group for creating more complex molecules. The hydroxyl function offers chemists a lever to introduce new motifs and break down multi-step pathways.
N-Butanol goes by several aliases: 1-Butanol, n-butyl alcohol, butan-1-ol. In laboratory catalogs, it might show up as NBA or n-Butyl Alcohol Pharma Grade. Commercial producers use their own branding on containers, but strict regulations keep the core nomenclature clear to avoid confusion. In a global supply chain, consistency in product identity prevents shipment errors and helps maintain traceability in manufacturing.
Working safely with n-Butanol means understanding its risks. Vapors irritate the eyes and respiratory tract. The liquid absorbs through the skin, and accidental swallowing can trigger dizziness or nausea. Facilities require proper ventilation, splash-proof goggles, gloves, and chemical-resistant aprons for every handling task. Spill kits and fume hoods sit close to n-Butanol workstations. Storage away from direct sunlight and sources of ignition limits fire risk. Regulatory bodies like OSHA and the European Chemicals Agency set permissible exposure limits, and pharmaceutical standards demand detailed documentation at every point. Beyond compliance, a culture of safety grows from habit—frequent training and reinforcement keep the workplace safer.
N-Butanol earns its keep across several pharmaceutical and biotechnology roles. As a solvent, it cleans up active pharmaceutical ingredients and extracts herbal compounds for analysis. It helps engineers create uniform coatings on tablets and capsules, ensuring controlled release or protective layers. Those in diagnostics appreciate n-Butanol’s compatibility with reagent formulations. In molecular biology, it separates DNA, RNA, and proteins during extraction protocols, thanks to selective solubility properties. Beyond drugs, it aids in flavor production and vaccine purification, often blending with similar alcohols to tweak polarity and volatility. Its role may not always make headlines, but without it, processes slow and results turn inconsistent.
Ongoing research continues to expand the range of n-Butanol’s applications. Teams seek new, greener production routes, examining bio-based sources or genetically engineered microbes. Environmental concerns shape R&D, with scientists focused on lowering carbon footprints along the supply chain. Landscape studies track impurities that could impact downstream biological assays, tweaking purification systems for extra margin of safety. Labs experiment with n-Butanol as a precursor for novel prodrugs, where biotransformation releases the active substance only in target tissues. Other projects use it as a phase-separation agent in high-throughput screening, pushing the limits of analytical detection. The drive to automate and digitize manufacturing has also brought n-Butanol quality into tighter focus, with digital batch tracking kicking in at every production step.
Toxicologists keep a close eye on n-Butanol’s health effects. Animal and cell studies trace how exposure impacts metabolism, organ function, and endpoints like carcinogenicity. Short exposures lead to central nervous system depression, mirroring effects seen with ethanol, though symptoms often take higher doses to appear. Long-term testing in rodents has not pointed to clear evidence of carcinogenicity, but limitations in dose and duration mean regulatory agencies still consider it with caution. Toxicology researchers helped shape permissible workplace exposure limits, setting standards based on real risk rather than guesswork. Medical professionals report occasional cases of accidental poisoning, but outcomes rely on quick supportive care and prevention, rather than drastic intervention.
The prospects for n-Butanol often tie to broader shifts in energy, medicine, and green chemistry. Synthetic biology could one day supply most of the demand through bioengineered fermentation, using agricultural waste rather than crude oil. The pharmaceutical industry’s pursuit of greener solvents points to n-Butanol as a safer substitute for harsher, more toxic chemicals. Regulatory scrutiny of impurities and sustainability metrics will likely push manufacturers to upgrade testing and reporting infrastructure. There’s plenty of opportunity in developing low-residue formulations for sensitive biologic drugs, tapping into emerging needs for precision delivery systems. As automation, robotics, and AI transform pharma manufacturing, the traceability and purity demands for every minor additive—including n-Butanol—look set to climb higher. These challenges require collaboration between chemists, engineers, and regulators—real people, facing real questions about safety, cost, and progress.
N-Butanol, especially at pharma grade, finds regular use in the pharmaceutical sector for good reason. Quality in raw materials plays a big role when medicines and health products get made, and regulatory standards like BP, EP, and USP point to that high bar. N-Butanol serves as a solvent in antibiotics, vitamins, and even hormones. Its performance rests on its ability to interact with a range of substances in a controlled, predictable way. I’ve seen manufacturers choose pharma grade materials because even a slight impurity can ripple through into the benefits or safety of the end product. If a solvent leaves a residue, that’s not something you want landing in medicine.
In chemical processing, the way n-Butanol dissolves active ingredients makes it a practical tool. Whether blending an extract with a tablet or creating an injectable, consistency isn’t negotiable. The pharma grade version guarantees minimal contaminants, so both the manufacturer and the consumer know what’s going in. This gives doctors some confidence too, since the success of a medication sometimes rides on how clean its ingredients are. I’ve learned from industry peers that inspections often focus on these points — no company wants a recall due to a misstep that starts with the solvent.
Even outside the final pill or bottle, n-Butanol steps up in labs during research and quality checks. Chemists pick it to extract or purify molecules without introducing unwanted extras. This matters during early-stage drug development and during routine quality monitoring. If you work in pharma research, sticking to recognized standards like BP, EP, or USP means less retesting and fewer surprises. The amount of time saved or mistakes avoided by choosing certified solvents doesn’t get highlighted enough.
On manufacturing floors, n-Butanol supports production of both over-the-counter and prescription drugs. Its use isn’t flashy, but missing it can shut things down or force a frustrating search for alternatives. Since n-Butanol works well with both water-soluble and fat-soluble ingredients, it supports both classic tablets and newer formulations such as gels or soft capsules. This flexibility reduces bottlenecks in production. Regulatory audits always check the paperwork, and using pharma grade solvents helps keep things smooth during reviews.
People sometimes worry about chemical exposure, even from pharma grade ingredients. Strong oversight offers one answer. Certification bodies set the rules, but companies also keep up regular batch testing. Traceability lets manufacturers recall a batch quickly if concerns pop up, and open records keep regulators in the loop. Another solution ties back to staff training. Techs who know the chemistry behind their materials catch issues quicker. Safety measures, such as proper handling, storage, and disposal protocols, protect both workers and end-users from accidental exposure.
With new drugs and delivery options hitting the market, the demand for high-grade manufacturing aids keeps growing. Choosing rigorously tested ingredients like n-Butanol BP EP USP grade isn’t just ticking boxes — it helps reduce recalls, cuts risks, and supports better patient outcomes. My own take is that relying on this sort of quality will remain non-negotiable as global health standards keep climbing.
N-Butanol shows up on the ingredient lists for a wide range of pharmaceutical processes. It acts as a solvent, churning out consistent results in reactions, extractions, and crystal formations. Still, opening a drum stamped “n-butanol” doesn’t guarantee it's ready for mixing with tomorrow’s medication batches. The gap between industrial-grade and pharma-grade runs deep. Cutting corners on purity or quality never ends well when public health hangs in the balance.
Every lot of n-butanol meant for drug manufacturing needs to meet set thresholds for purity. Impurities just above safe limits can throw off a delicate chemical process or leave residues that pile up and risk patient safety. For reference, the United States Pharmacopeia (USP) and European Pharmacopoeia list clear specs—often above 99.5% pure, low levels of water, and virtual absence of heavy metals or organic residues that could disrupt workflows or break compliance.
I’ve seen cases where a single contaminant, undetected during purchase, forced an entire batch to get scrapped. Switching suppliers or going with a cheaper option may save money on paper, but once analytical results come back flagged, those savings vanish. There’s no substitute for batch-tested material with certificates of analysis proving it’s up to scratch.
It’s not only about what’s inside the bottle—the paperwork can matter just as much. In regulated manufacturing, every drum must arrive with a clear, auditable trail. Suppliers need to provide validated test results, clear batch numbers, and proof that procedures followed the right GMP (Good Manufacturing Practice) standards. Even if the chemistry checks out, a lack of transparency forces plants to pause operations or do repeat analyses.
Relying on respected, certified suppliers who understand these needs keeps the supply chain predictable. In my experience, factories that integrate supplier audits and random checks of incoming chemicals save themselves future headaches. Trust earned through good documentation keeps regulators, auditors, and patients’ families confident in the process.
Local manufacturers sometimes promise quicker lead times, but they can lack the full GMP certifications or regularly fail on traceable paperwork. Global providers recognized by the FDA and EMA cost more, yet they seldom fall short on compliance. Direct visits to supplier sites, reviewing audit records, and checking prior regulatory inspections help catch warning signs before contracts get signed.
Building a robust evaluation checklist helps teams sort suitable from unsuitable n-butanol. Routine verification of supplier GMP compliance lowers the risk of sub-quality material arriving at the plant. Keeping tight relationships with qualified wholesalers means quicker troubleshooting during shortages. Investing upfront in supplier partnerships, instead of chasing last-minute bulk discounts, pays off. Companies can also conduct their own spot tests alongside supplier data, pairing independent analytics with documentation.
Every step—quality checks, supplier vetting, and clear records—guards against costly mistakes. Much of pharmaceutical manufacturing depends on details that can seem minor until a safety or quality scare reminds everyone that there’s simply too much at stake.
As someone who’s worked in chemical distribution, I’ve seen a shipment turn south from just a small packaging slipup. With N-Butanol that meets BP, EP, or USP standards, no detail gets overlooked. This alcohol carries strict expectations since it’s used in active pharmaceutical production, lab reagents, and even as a flavoring in some cases. Everything, even the drums or tanks, can impact what you end up with on the production line.
Most pharma-grade N-Butanol moves in tight-sealed steel drums, usually in 180 to 200-liter volumes. Stainless steel or HDPE containers also make the cut, especially for smaller or more frequent users. I’ve handled 20-liter carboys for labs and 1,000-liter IBC tanks for big processing plants. If you’re buying in large batches, ISO tanks and tank trucks become the norm, cutting contamination risks when properly dedicated to pharma use.
No one in the pharma chain risks open-head drums or cheap plastics. The containers carry tamper-evidence and certificates with traceability. From my experience, any deviation in these packing basics triggers rejected deliveries and quality investigations. Even a tiny scratch inside a drum can become a recall reason since it might leach metals or compromise purity.
Suppliers typically offer a shelf life of two to three years, provided storage fits pharma-grade demands: cool, dry, and well-ventilated spaces, away from sunlight or ignition sources. I’ve watched warehouse staff rig up special racks just to keep the containers upright and uncrowded. Caps and seals need regular checks, or water can creep in, and for N-Butanol, even a little moisture tips the bottle from pharma purity to technical grade.
The chemical itself doesn’t break down fast. But what really eats into shelf life? Shifts in temperature, leaky lids, or exposure to air. If a drum is opened and not fully used, manufacturers recommend close monitoring and a shorter expiration window. No matter what suppliers claim, on-site QA teams pull off random tests to make sure there’s no betrayal from packaging or storage lapses.
Ignoring best packaging practices leads to a domino effect. I’ve seen operators try to save a buck with generic drums. Within months, yellowed color or strange odors set off alarms. Even if the changes look minor, failing a pharmacopeia test around alcohol purity or heavy metals means the whole batch gets tossed. In regulated markets, such waste can set back a project by months.
Quality packaging doesn’t just mean picking any steel drum off the rack; it’s about source verification, drum lining certifications, lot stamps, and traceable seals. Staff need regular training to spot damage or expired stock. Environmental monitoring in storage areas backs up shelf-life promises. Some suppliers offer consignment arrangements so customers always get fresh lots within their chemical’s best period.
To keep downstream risks low, many buyers set lots aside for stability testing even before production. Pharmacopeia standards keep tightening, and real-world feedback from frontline workers and pharmacists remains essential. The biggest fails I’ve seen come from basic miscommunications: wrong drum sizes, missing label info, unreported minor damage. A little vigilance at receipt saves weeks of troubleshooting later.
Every box sitting on the shelf or barrel stashed in a warehouse comes with a promise – that what’s inside matches what’s on the label. Purity isn’t just an industry buzzword. It’s the clear line between a product that performs as expected and one that leaves users exposed to risks. I remember a client who bought a cleaning solvent for a machine shop and saw the finish on his parts get ruined. The culprit turned out to be tiny impurities in the mix. He learned that what looks “good enough” can send expensive equipment straight to the repair shop. People count on reliable sourcing and honest documentation so they can focus on their work, not on what might be lurking in their materials.
International and regional regulations shape how companies work. Take the United States Pharmacopeia (USP) for pharmaceuticals or the Food Chemicals Codex (FCC) for food additives. These standards lay down hard numbers: minimum purity levels and maximum tolerated contaminants. The numbers aren’t just picked out of thin air. Years of research underline these limits, tracking how different elements react in real-world environments.
The European Union pushes mandatory REACH compliance for chemicals. This process checks for substances of very high concern, ruling out those known to cause long-term harm. Across Asia and South America, national agencies often build on these foundations, matching or adapting standards to local needs and risks. For food and supplements, organizations like the WHO and local health ministries often work together, setting colorants, sweeteners, and other additives within defined purity margins.
Regulators step in with routine audits and random sampled tests. I once spent a week at a packing facility where inspectors checked every invoice, tested random product batches, and verified cleaning logs. It felt tedious, but the result was simple: customers ended up with consistent, safe products. Companies back up purity guarantees with certificates of analysis (COAs), generated from their own labs or independent third parties. These documents outline specific impurity thresholds, from heavy metals to microbial loads.
Supply chains only work when every link holds up under this scrutiny. One slip—from a contaminated shipment, to a missing test report—can bring recalls, lawsuits, or loss of export privileges. Companies aware of the stakes invest in training, laboratory equipment, and traceability tools. It pays off: problems get caught early, before they hit the market or cause harm.
Technology is making a difference. Portable analyzers give real-time feedback without long wait times. Blockchain and cloud tracking systems make recordkeeping more trustworthy and accessible, cutting the risk of tampering or human error.
Education plays a key role too. Customers who check labels and request supporting documents force suppliers to keep quality at the front of every decision. Online platforms and databases help cross-reference lab standards and red-flag risky suppliers. I’ve noticed smaller businesses now making use of third-party audits and public certifications, not just the big multinationals.
Every party involved shares responsibility for upholding these standards. Strong compliance makes life safer and simpler for everyone: manufacturers, consumers, and the workers caught in-between. Each step toward better transparency leads to greater trust in the marketplace.
In a busy lab or pharmaceutical plant, folks work daily with all sorts of chemicals that seem simple on paper. N-Butanol stands out as a solvent and an ingredient used for pharmaceutical formulations, coatings, and more. What really matters here isn’t just the grade—it’s how we treat it the moment that drum lands on our doorstep. Let’s talk about safe and smart ways to store and handle this chemical, drawing from lessons learned on the job and what the evidence tells us.
Many accidents in pharmaceutical or chemical facilities start with poor storage and sloppy handling routines. N-Butanol seems common but it brings its own set of risks. A colorless, flammable liquid with a noticeable smell, it evaporates fast and reacts to heat easily. Keeping it in a cool, well-ventilated spot makes real sense. If you’ve ever experienced a headache after a whiff of solvent, you’ll know air circulation isn’t just checking a box—it keeps people healthy and alert.
The drum or container should never sit in direct sunlight or near something that could spark. Temperatures rise in a sunroom, and vapors collect when airflow doesn’t move. That means avoiding cramped closets and instead picking solid shelving or a chemical-resistant cabinet. Spills on a warm day become a much bigger deal, making fires and harmful fumes much more likely.
Anyone who’s worked with solvents has seen the result of a sloppy seal—a ring of crust below the cap, a faint stench wafting out, maybe even some students or workers complaining near the storage. A tight seal prevents not just waste but unhealthy air. Every time you use some N-Butanol, check those lids.
Labeling goes beyond a sticker with a name. Review hazard symbols, storage instructions, and expiry dates before shelving anything. Mislabeling or no labeling leads to mistaken swaps in the lab. That risk multiplies when people rush or new staff join the team. Over time, good habits with labels protect workers, projects, and anyone walking by.
N-Butanol exposure might not cause trouble at first. Contact over time can hurt skin, eyes, and lungs. Proper gloves, goggles, and lab coats keep these worries at bay. I’ve seen workers skip gloves “just for a minute,” only to regret it with red hands by lunch. Working safely means planning ahead, no matter how busy the morning gets.
I’ve lived through more than one chemical spill that was much less dramatic than folks imagine—and also some that set off alarms. Small or large, all of them cause wasted time and stress. Keep spill kits nearby, stocked with absorbent materials and neutralizers suited for N-Butanol. Practice how to deal with leaks; don’t leave it as something “the safety officer does once a year.”
Waste handling can get overlooked. Leftover N-Butanol isn’t just another bit of trash. Flammable waste containers should stay sealed and separately stored, far from where people work or relax. Partner with certified disposal teams to handle this part, since homegrown solutions always bring extra risks and, sometimes, surprise visits from regulators.
Each decision about storage or handling shapes the health of your crew and the success of projects. Remain consistent about routines. Share updates and make time for walk-throughs together. People remember stories about accidents—use those to reinforce habits that keep everyone safer, stronger, and more confident when handling N-Butanol in everyday pharmaceutical settings.
| Thermochemistry | |
| Std enthalpy of formation (ΔfH⦵298) | -327.0 kJ/mol |
Chengguan District, Lanzhou, Gansu, China
